UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non‐small cell lung cancer

Cancer science, 2020-12, Vol.111 (12), p.4442-4452

2020

Volltextzugriff (PDF)

Efficacy of chemotherapy plus immune checkpoint inhibitors in patients with non-small cell lung cancer who have rare oncogenic driver mutations: a retrospective analysis

BMC cancer, 2024-07, Vol.24 (1), p.842-10, Article 842

2024

Volltextzugriff (PDF)

The incidence of drug-induced interstitial lung disease caused by epidermal growth factor receptor tyrosine kinase inhibitors or immune checkpoint inhibitors in patients with non-small cell lung cancer in presence and absence of vascular endothelial growth factor inhibitors: a systematic review

Frontiers in oncology, 2024, Vol.14, p.1419256

2024

Volltextzugriff (PDF)

Risk factors for pneumonitis in patients with non‐small cell lung cancer treated with immune checkpoint inhibitors plus chemotherapy: A retrospective analysis

Thoracic cancer, 2022-03, Vol.13 (5), p.724-731

2022

Volltextzugriff (PDF)

Chemotherapy for extensive-stage small-cell lung cancer with idiopathic pulmonary fibrosis

International journal of clinical oncology, 2014-04, Vol.19 (2), p.260-265

2014

Volltextzugriff (PDF)

Docetaxel for platinum-refractory advanced thymic carcinoma

Japanese journal of clinical oncology, 2015-07, Vol.45 (7), p.665-669

2015

Volltextzugriff (PDF)

Emerging therapies for non-small cell lung cancer harboring EGFR exon 20 insertion mutations: narrative review

Annals of translational medicine, 2022-12, Vol.10 (23), p.1283-1283

2022

Volltextzugriff (PDF)

Elements of End-of-Life Discussions Associated With Patients' Reported Outcomes and Actual End-of-Life Care in Patients With Pretreated Lung Cancer

The oncologist (Dayton, Ohio), 2024-02, Vol.29 (2), p.e282-e289

2024

Volltextzugriff (PDF)

Second-line docetaxel for patients with platinum-refractory advanced non-small cell lung cancer and interstitial pneumonia

Cancer chemotherapy and pharmacology, 2015-07, Vol.76 (1), p.69-74

2015

Volltextzugriff (PDF)

Prognostic Awareness and Discussions of Incurability in Patients with Pretreated Non-Small Cell Lung Cancer and Caregivers: A Prospective Cohort Study

The oncologist (Dayton, Ohio), 2022-11, Vol.27 (11), p.982-990

2022

Volltextzugriff (PDF)

Unrealistic expectations and disclosure of incurability in patients with non-small cell lung cancer

Supportive care in cancer, 2024-07, Vol.32 (7), p.421, Article 421

2024

Volltextzugriff (PDF)

Efficacy and Safety of Combined Carboplatin, Paclitaxel, and Bevacizumab for Patients with Advanced Non-squamous Non-small Cell Lung Cancer with Pre-existing Interstitial Lung Disease: A Retrospective Multi-institutional Study

Anticancer research, 2015-07, Vol.35 (7), p.4259-4263

2015

Volltextzugriff (PDF)

Efficacy and Safety Data of Osimertinib in Elderly Patients with NSCLC Who Harbor the EGFR T790M Mutation After Failure of Initial EGFR-TKI Treatment

Anticancer research, 2018-09, Vol.38 (9), p.5231-5237

2018

Volltextzugriff (PDF)

Vinorelbine and cisplatin in patients with advanced non-small cell lung cancer with interstitial pneumonia

Anticancer research, 2015-03, Vol.35 (3), p.1697-1701

2015

Volltextzugriff (PDF)

Crizotinib-induced acute interstitial lung disease in a patient with EML4-ALK positive non-small cell lung cancer and chronic interstitial pneumonia

Acta oncologica, 2014-01, Vol.53 (1), p.158-160

2014

Volltextzugriff (PDF)

Clinical Predictors of Response to EGFR Tyrosine Kinase Inhibitors in Patients with EGFR-Mutant Non-Small Cell Lung Cancer

Oncology, 2014-01, Vol.86 (2), p.86-93

2014

Volltextzugriff (PDF)

Phase II Study of Carboplatin and Pemetrexed in Advanced EGFR-wild-type Non-squamous Non-small Cell Lung Cancer: The Central Japan Lung Study Group Trial 0906

Anticancer research, 2016-04, Vol.36 (4), p.1767-1771

2016

Volltextzugriff (PDF)

Prognosis in patients with non-small cell lung cancer who received erlotinib treatment and subsequent dose reduction due to skin rash

Onkologie, 2012-12, Vol.35 (12), p.747-752

2012

Volltextzugriff (PDF)

Enhancement of clonal proliferation of mouse mast cells by a tumor-promoting phorbol ester

Cancer research (Chicago, Ill.), 1984-05, Vol.44 (5), p.2110-2114

1984

Volltextzugriff (PDF)

Utility of immune checkpoint inhibitors in non‐small‐cell lung cancer patients with poor performance status

Cancer science, 2020-10, Vol.111 (10), p.3739-3746

2020

Volltextzugriff (PDF)

The impact of body mass index on the efficacy of anti-PD-1/PD-L1 antibodies in patients with non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2020-01, Vol.139, p.140-145

2020

Volltextzugriff (PDF)

Frequent mutations of genes encoding vacuolar H+‐ATPase components in granular cell tumors

Genes chromosomes & cancer, 2019-06, Vol.58 (6), p.373-380

2019

Volltextzugriff (PDF)

Preoperative Bone Loss Predicts Decreased Survival Associated with Microvascular Invasion after Resection of Hepatocellular Carcinoma

Cancers, 2024-05, Vol.16 (11), p.2087

2024

Volltextzugriff (PDF)

Osteopenia Is Associated with Shorter Survival in Patients with Intrahepatic Cholangiocarcinoma

Current oncology (Toronto), 2023-02, Vol.30 (2), p.1860-1868

2023

Volltextzugriff (PDF)

Nintedanib can be used safely and effectively for idiopathic pulmonary fibrosis with predicted forced vital capacity ≤ 50%: A multi-center retrospective analysis

PloS one, 2020-08, Vol.15 (8), p.e0236935-e0236935

2020

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(68)

Publikationsform

Artikel
(68)

Sprache

Englisch
(68)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(66)
Life Sciences & Biomedicine
(65)
Humans
(46)
Female
(35)
Male
(34)
Middle Aged
(33)
Aged
(32)
Adult
(22)
Retrospective Studies
(20)
Patients
(19)
Tumors
(19)
Chemotherapy
(18)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(15)
Lung Neoplasms - Drug Therapy
(15)
Cancer Research
(14)
Lung Cancer
(14)
Medicine
(14)
Prognosis
(14)
Aged, 80 And Over
(13)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non‐small cell lung cancer

Efficacy of chemotherapy plus immune checkpoint inhibitors in patients with non-small cell lung cancer who have rare oncogenic driver mutations: a retrospective analysis

The incidence of drug-induced interstitial lung disease caused by epidermal growth factor receptor tyrosine kinase inhibitors or immune checkpoint inhibitors in patients with non-small cell lung cancer in presence and absence of vascular endothelial growth factor inhibitors: a systematic review

Risk factors for pneumonitis in patients with non‐small cell lung cancer treated with immune checkpoint inhibitors plus chemotherapy: A retrospective analysis

Chemotherapy for extensive-stage small-cell lung cancer with idiopathic pulmonary fibrosis

Docetaxel for platinum-refractory advanced thymic carcinoma

Emerging therapies for non-small cell lung cancer harboring EGFR exon 20 insertion mutations: narrative review

Elements of End-of-Life Discussions Associated With Patients' Reported Outcomes and Actual End-of-Life Care in Patients With Pretreated Lung Cancer

Second-line docetaxel for patients with platinum-refractory advanced non-small cell lung cancer and interstitial pneumonia

Prognostic Awareness and Discussions of Incurability in Patients with Pretreated Non-Small Cell Lung Cancer and Caregivers: A Prospective Cohort Study

Unrealistic expectations and disclosure of incurability in patients with non-small cell lung cancer

Efficacy and Safety of Combined Carboplatin, Paclitaxel, and Bevacizumab for Patients with Advanced Non-squamous Non-small Cell Lung Cancer with Pre-existing Interstitial Lung Disease: A Retrospective Multi-institutional Study

Efficacy and Safety Data of Osimertinib in Elderly Patients with NSCLC Who Harbor the EGFR T790M Mutation After Failure of Initial EGFR-TKI Treatment

Vinorelbine and cisplatin in patients with advanced non-small cell lung cancer with interstitial pneumonia

Crizotinib-induced acute interstitial lung disease in a patient with EML4-ALK positive non-small cell lung cancer and chronic interstitial pneumonia

Clinical Predictors of Response to EGFR Tyrosine Kinase Inhibitors in Patients with EGFR-Mutant Non-Small Cell Lung Cancer

Phase II Study of Carboplatin and Pemetrexed in Advanced EGFR-wild-type Non-squamous Non-small Cell Lung Cancer: The Central Japan Lung Study Group Trial 0906

Prognosis in patients with non-small cell lung cancer who received erlotinib treatment and subsequent dose reduction due to skin rash

Enhancement of clonal proliferation of mouse mast cells by a tumor-promoting phorbol ester

Utility of immune checkpoint inhibitors in non‐small‐cell lung cancer patients with poor performance status

The impact of body mass index on the efficacy of anti-PD-1/PD-L1 antibodies in patients with non-small cell lung cancer

Frequent mutations of genes encoding vacuolar H+‐ATPase components in granular cell tumors

Preoperative Bone Loss Predicts Decreased Survival Associated with Microvascular Invasion after Resection of Hepatocellular Carcinoma

Osteopenia Is Associated with Shorter Survival in Patients with Intrahepatic Cholangiocarcinoma

Nintedanib can be used safely and effectively for idiopathic pulmonary fibrosis with predicted forced vital capacity ≤ 50%: A multi-center retrospective analysis

Aktive Filter

Suchergebnisse filtern